Type:Notice
Citation:90 FR 10731
Reading Time:about a minute or two
Catalent Pharma Solutions, LLC has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances. The company plans to import these substances in finished dosage forms for clinical trials, research, and analytical activities. Comments or objections regarding this application can be submitted electronically by March 28, 2025. Any hearing requests should be sent to the DEA at their Springfield, Virginia address.
Simple Explanation
Catalent Pharma Solutions wants to bring certain special medicines from other countries into the U.S. so they can use them for important tests and studies. People have until March 28, 2025, to say if they have any concerns about this.